Notícias

J&J has more than 28 sources of blockbuster revenue.

Micron just posted one of the most explosive quarters in semiconductor history, yet the stock has cratered nearly 14% in a single week as three distinct threats converge on the memory giant. Whether this selloff is a gift or a warning depends entirely on which scenario plays out next.

Royal Caribbean still checks the most boxes.

Three numbers on Meta's income statement keep pulling my money back before the July 29 earnings call, and one of them proves something no other hyperscaler has managed to pull off yet.

Netflix Loses $100 Billion in Value After Weak Q3 Guidance Shakes Bulls

Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.

The market is pricing Alphabet like a legacy ad company with an AI problem, and that gap between perception and reality is exactly where the opportunity lives ahead of the July 22 earnings report.

During an interview with CNBC, JPMorgan’s Global Market Strategist, Hugh Gimber, said the chip sector's next leg higher depends on continued Big Tech AI spending.

Investing.com -- JPMorgan upgraded shares of 3M and Emerson Electric to Overweight from Neutral ahead of upcoming quarterly earnings, citing improving growth prospects, supportive end-market trends and expectations for stronger earnings momentum into 2027.

Intuitive Surgical Inc. (NASDAQ:ISRG) shares fell sharply after the medical technology company released second-quarter results that topped Wall Street forecasts but issued a full-year procedure growth outlook that failed to meet investor expectations.

The company doubled its 2026 buyback target to at least $5 billion after already repurchasing $4 billion of shares.

Truist Financial reports second-quarter earnings Friday, but investors may be more focused on what the leadership transition to incoming CEO Michael Lyons could mean for the bank’s strategy.

Tesla Stock Faces Its Biggest Test Yet. Here's What Investors Need to See

Cintas Corporation (NASDAQ:CTAS) was upgraded to ‘Buy’ from Neutral by Bank of America, which also raised its price objective to $230 from $200 after the company's better-than-expected fourth-quarter fiscal 2026 results and fiscal 2027 guidance came in above Wall Street expectations. The...

Reddit Inc (NYSE:RDDT) is expected to beat Wall Street's second-quarter revenue and EBITDA targets, according to Jefferies, which pointed to strong ad checks and improving user growth heading into the print. The brokerage said investor conversations point to expectations for revenue and...

United Airlines' Q2 earnings beat estimates as strong yields and broad revenue gains offset soaring fuel costs and margin pressure.

Abbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company reported second quarter 2026 results that topped Wall Street expectations and raised its full-year adjusted earnings guidance. The company posted adjusted diluted earnings per share of $1.31 for the...

The stock is still 25% off all-time highs.

Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.

Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) posted a 77% jump in second-quarter net profit and raised its capital spending forecast for the year, as the world's largest contract chipmaker rides sustained demand for AI processors. Net profit came in at $22.36 billion for the...

Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.

The healthcare company posted adjusted earnings of $1.31 a share in the second quarter, topping Wall Street's estimate of $1.28

Abbott Laboratories (NYSE:ABT) delivered stronger-than-expected second-quarter results and increased its full-year earnings guidance, sending its shares about 2. 5% higher in premarket trading.

GE Aerospace (NYSE:GE) delivered better-than-expected second-quarter results and upgraded its financial guidance for the full year, supported by continued strength in its commercial services business and improving operational performance. The company reported adjusted earnings of $2.

Investing.com -- Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.

UnitedHealth Stock Rallies as Profit, Revenue Top Wall Street Expectations

The jet engine maker lifted its adjusted EPS forecast to $7.65–$7.85, up from $7.10–$7.40, after revenue climbed 21% in the quarter

The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share

Investing.com -- GE Aerospace reported second-quarter results that exceeded analyst expectations and raised its full-year outlook across all metrics, driven by robust commercial services growth.

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.